MARDY LINDT FIONNE DIAZ: Open Payments
NPI 1346707221 · EASTVALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,881 in 95 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $314 · 2025 $2,881
Food & beverage: $2,805Education: $77
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $569 |
| Amgen Inc. | 20 | $494 |
| LEO Pharma Inc. | 5 | $306 |
| ABBVIE INC. | 20 | $278 |
| Novartis Pharmaceuticals Corporation | 8 | $220 |
| Incyte Corporation | 6 | $208 |
| Janssen Biotech, Inc. | 3 | $205 |
| Regeneron Healthcare Solutions, Inc. | 7 | $204 |
| UCB, Inc. | 8 | $195 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $135 |
Products named: DUPIXENT, Otezla, SKYRIZI, OPZELURA, TREMFYA, Bimzelx, ADBRY, SPEVIGO.
Industry payments across CA — which companies pay providers there.
